Filing Details

Accession Number:
0000899243-24-000243
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-03 20:41:46
Reporting Period:
2024-04-01
Accepted Time:
2024-04-03 20:41:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Madrigal Pharmaceuticals Inc. MDGL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1560782 M James Daly C/O Madrigal Pharmaceuticals, Inc.
200 Barr Harbor Drive, Suite 400
West Conshohocken PA 19428
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-01 20,000 $100.45 21,198 No 4 M Direct
Common Stock Acquisiton 2024-04-01 1,577 $105.08 22,775 No 4 M Direct
Common Stock Disposition 2024-04-01 6,809 $255.64 15,966 No 4 S Direct
Common Stock Disposition 2024-04-01 7,401 $256.50 8,565 No 4 S Direct
Common Stock Disposition 2024-04-01 3,604 $257.30 4,961 No 4 S Direct
Common Stock Disposition 2024-04-01 1,460 $258.28 3,501 No 4 S Direct
Common Stock Disposition 2024-04-01 200 $259.11 3,301 No 4 S Direct
Common Stock Disposition 2024-04-01 800 $262.01 2,501 No 4 S Direct
Common Stock Disposition 2024-04-01 178 $263.31 2,323 No 4 S Direct
Common Stock Disposition 2024-04-01 351 $264.89 1,972 No 4 S Direct
Common Stock Disposition 2024-04-01 500 $265.49 1,472 No 4 S Direct
Common Stock Disposition 2024-04-01 274 $266.91 1,198 No 4 S Direct
Common Stock Acquisiton 2024-04-02 10,912 $105.08 12,110 No 4 M Direct
Common Stock Disposition 2024-04-02 842 $243.26 11,268 No 4 S Direct
Common Stock Disposition 2024-04-02 6,279 $244.19 4,989 No 4 S Direct
Common Stock Disposition 2024-04-02 2,991 $244.89 1,998 No 4 S Direct
Common Stock Disposition 2024-04-02 557 $246.30 1,441 No 4 S Direct
Common Stock Disposition 2024-04-02 43 $247.03 1,398 No 4 S Direct
Common Stock Disposition 2024-04-02 200 $248.45 1,198 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-04-01 20,000 $0.00 20,000 $100.45
Common Stock Stock Option (Right to Buy) Disposition 2024-04-01 1,577 $0.00 1,577 $105.08
Common Stock Stock Option (Right to Buy) Disposition 2024-04-02 10,912 $0.00 10,912 $105.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-06-27 No 4 M Direct
10,912 2024-06-17 No 4 M Direct
0 2024-06-17 No 4 M Direct
Footnotes
  1. (1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.01 to $256.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.01 to $257.00, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.01 to $258.00, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.01 to $258.93, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.10 to $259.12, inclusive.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.59 to $262.15, inclusive.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.09 to $264.07, inclusive.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.11 to $265.07, inclusive.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.35 to $265.64, inclusive.
  11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.73 to $267.21, inclusive.
  12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.58 to $243.56, inclusive.
  13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.60 to $244.58, inclusive.
  14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.61 to $245.53, inclusive.
  15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.62 to $246.54, inclusive.
  16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.72 to $247.24, inclusive.
  17. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.96 to $248.72, inclusive.
  18. The shares underlying this option are fully vested and exercisable.